EQS-Adhoc: MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year
|
EQS-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Change in Forecast Bremen, September 4, 2024 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, is adjusting its annual forecast for the current fiscal year based on the preliminary business figures for the first eleven months.
The reasons for the decline in sales are an unexpected cautiousness in purchasing behavior due to global economic challenges. In addition, the result will be strongly impacted by the development of the US dollar/euro exchange rate since the beginning of the fiscal year.
************************************************************************ Contact: Kirchhoff, Marcus / CEO End of Inside Information
04-Sep-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | MeVis Medical Solutions AG |
| Caroline-Herschel-Str. 1 | |
| 28359 Bremen | |
| Germany | |
| Phone: | +49 421 224 95 0 |
| Fax: | +49 421 224 95 999 |
| E-mail: | ir@mevis.de |
| Internet: | http://www.mevis.de |
| ISIN: | DE000A0LBFE4 |
| WKN: | A0LBFE |
| Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1981763 |
| End of Announcement | EQS News Service |
|
|
1981763 04-Sep-2024 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | ||
| Sales1 | 16,76 | 18,07 | 17,13 | 16,21 | 18,76 | 17,34 | 18,30 | |
| EBITDA1,2 | 7,60 | 8,25 | 5,97 | 4,77 | 7,99 | 3,99 | 4,91 | |
| EBITDA-Margin3 | 45,35 | 45,66 | 34,85 | 29,43 | 42,59 | 23,01 | 26,83 | |
| EBIT1,4 | 6,69 | 8,00 | 5,81 | 4,64 | 7,90 | 3,89 | 4,80 | |
| EBIT-Margin5 | 39,92 | 44,27 | 33,92 | 28,62 | 42,11 | 22,43 | 26,23 | |
| Net Profit (Loss)1 | 7,17 | 8,07 | 5,70 | 4,55 | 7,79 | 4,92 | 5,70 | |
| Net-Margin6 | 42,78 | 44,66 | 33,28 | 28,07 | 41,53 | 28,37 | 31,15 | |
| Cashflow1,7 | 5,52 | 6,55 | 2,89 | 9,13 | 4,86 | 5,85 | 0,00 | |
| Earnings per share8 | 3,94 | 4,43 | 3,13 | 2,50 | 4,28 | 2,70 | 3,15 | |
| Dividend per share8 | 0,95 | 0,95 | 0,95 | 0,95 | 0,95 | 0,95 | 0,95 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: Deloitte
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| MeVis Med. Solutions | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A0LBFE | DE000A0LBFE4 | AG | 44,41 Mio € | 16.11.2007 | Halten | 9F5C4V35+HX |
| PE 2025e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 10,17 | 10,24 | 0,99 | 7,43 | 2,49 | 7,59 | 2,56 |
|
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
| 0,95 | 0,95 | 0,95 | 3,89% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 19.03.2024 | - | 27.05.2025 | - | 30.01.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +0,25% | -2,36% | -3,17% | -3,17% | -55,64% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
